In vitro susceptibility to different topical ophthalmic antibiotics of bacterial isolates from patients with conjunctivitis.

Détails

ID Serval
serval:BIB_783726244421
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
In vitro susceptibility to different topical ophthalmic antibiotics of bacterial isolates from patients with conjunctivitis.
Périodique
Ocular immunology and inflammation
Auteur⸱e⸱s
Giardini F., Grandi G., De Sanctis U., Eandi C., Machetta F., Pollino C., Grignolo F.M.
ISSN
1744-5078 (Electronic)
ISSN-L
0927-3948
Statut éditorial
Publié
Date de publication
12/2011
Peer-reviewed
Oui
Volume
19
Numéro
6
Pages
419-421
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
To test in vitro the susceptibility to different commercially-available topical antibiotics of isolates from patients with conjunctivitis, evaluated at the Microbiology Service of Turin Ophthalmic Hospital between January 2005-February 2007.
Bacterial isolates were cultured using both liquid and solid media. The four most frequent isolates were analyzed and their in vitro susceptibility to levofloxacin, ofloxacin, norfloxacin, lomefloxacin, tobramycin, netilmycin, ampicillin, and chloramphenicol was tested, using the Kirby-Bauer diffusion method and National Committee for Clinical Laboratory Standards (NCCLS) serum standards.
The four most common bacteria isolates were: Staphylococcus aureus (27%), viridians Streptococci (22%), Staphylococcus epidermidis (16%) and Streptococcus pneumoniae (13%). The in vitro susceptibility to levofloxacin was highest (p<0.01) for all bacterial isolates.
In vitro susceptibility tests showed that levofloxacin had the highest cumulative efficacy against bacterial isolates. Netilmycin showed the highest efficacy against staphylococcus aureus, the most common bacterial isolate in this study.
Mots-clé
Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Bacteria/isolation & purification, Conjunctivitis, Bacterial/microbiology, Drug Resistance, Bacterial, Humans, Italy, Microbial Sensitivity Tests, Retrospective Studies, Staphylococcus aureus/drug effects, Staphylococcus aureus/isolation & purification, Staphylococcus epidermidis/drug effects, Staphylococcus epidermidis/isolation & purification, Streptococcus pneumoniae/drug effects, Streptococcus pneumoniae/isolation & purification, Viridans Streptococci/drug effects, Viridans Streptococci/isolation & purification
Pubmed
Web of science
Création de la notice
12/03/2021 9:43
Dernière modification de la notice
26/03/2021 6:35
Données d'usage